INSP Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Inspire Medical Systems, Inc.

Core Points - A class action has been filed against Inspire Medical Systems, Inc. for allegedly misleading investors regarding the Inspire V device launch [1][2] - The Inspire V device is intended for treating obstructive sleep apnea and was marketed as a groundbreaking product [2] - The launch of Inspire V faced significant challenges, including poor demand and inadequate preparation by the company [3] Allegations - Inspire Medical Systems failed to complete essential tasks for the successful launch of Inspire V, such as training for treatment centers and updating IT systems [3] - The company did not ensure that Medicare reimbursement was in place at the time of the launch, which contributed to the launch's difficulties [3] Financial Impact - On August 4, 2025, Inspire revealed that the launch was facing an "elongated timeframe," leading to a drastic reduction in 2025 earnings guidance by over 80% [4] - Following this announcement, the stock price plummeted by $42.04 per share, a decline of more than 32%, resulting in a loss of $1.2 billion in market capitalization in one day [4] - From a high of $216.71 per share on September 23, 2024, the stock price dropped nearly 60%, erasing billions from the company's market capitalization [4]